FDA clears Thermo Scientific blood test for use in U.S.
New blood test is designed to reduce the number of false positive results and provide improved diagnostic guidance in Systemic Lupus Erythematosus
New blood test is designed to reduce the number of false positive results and provide improved diagnostic guidance in Systemic Lupus Erythematosus
Fusion Antibodies and Eurofins Discovery sign co-marketing agreement to support timely and cost-effective development of innovative products for the benefit of global healthcare.
R&D manager Yahya Nuruddeen supervises multiple research teams. Here, he explains how reviews have helped him make the right decision for their laboratories
PD-L1 IHC 22C3 pharmDx can now be used as an aid to identify esophageal cancer patients for treatment with KEYTRUDA (pembrolizumab)
The new MaxSignal Mycotoxin Automation Bundle enables faster time to result, lower cost per sample and increased productivity
The new all-in-one digital inspection solution from Leica Microsystems
Experience the solutions new functions with a free trial on the Aivia web platform
Gain insights on topics from point-of-care cardiac troponin, CRISPR editing efficiency, targeted biomarker measurements for precision medicine & more
Sengenics CSO and inventor of the KREX™ protein folding technology, Professor Jonathan Blackburn, discusses the applications of KREX™ for the discovery of autoantibody-based companion diagnostics and early disease detection biomarkers, as well as the potential benefits in the treatment of autoimmune disease, cancer, neurological and infectious diseases and beyond
QIAreach SARS-CoV-2 Antigen Test, developed in collaboration with Ellume, provides accurate and objective results in 2 to 15 minutes
Obtaining two vaccine doses remains the most effective way to ensure protection against the COVID-19 Delta variant
Fewer than one in 20 children with symptomatic COVID-19 experienced symptoms lasting longer than 4 weeks, and almost all children have fully recovered by 8 weeks
Patients with underlying heart problems are more than four times as likely to die from COVID-19
Low-cost device lets consumers check themselves for multiple strains of SARS-CoV-2 at home